BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 3941708)

  • 1. Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension.
    Weder AB
    N Engl J Med; 1986 Jan; 314(4):198-201. PubMed ID: 3941708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sodium-lithium countertransport in red cells of patients with essential hypertension.
    Canessa M; Adragna N; Solomon HS; Connolly TM; Tosteson DC
    N Engl J Med; 1980 Apr; 302(14):772-6. PubMed ID: 7354809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium-lithium countertransport is not a marker of proximal tubular sodium clearance.
    Maling TJ; Siebers RW
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S50-1. PubMed ID: 1708024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbation of sodium-lithium countertransport in red cells.
    Woods JW; Parker JC; Watson BS
    N Engl J Med; 1983 May; 308(21):1258-61. PubMed ID: 6843610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium-sodium countertransport: physiological moorings for red cell transport disorders in hypertension.
    Weder AB; Fitzpatrick MA
    J Cardiovasc Pharmacol; 1986; 8 Suppl 5():S76-81. PubMed ID: 2427890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy.
    Mangili R; Bending JJ; Scott G; Li LK; Gupta A; Viberti G
    N Engl J Med; 1988 Jan; 318(3):146-50. PubMed ID: 3336402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in glomerular filtration rate in patients with insulin-dependent diabetes and elevated erythrocyte sodium-lithium countertransport.
    Carr S; Mbanya JC; Thomas T; Keavey P; Taylor R; Alberti KG; Wilkinson R
    N Engl J Med; 1990 Feb; 322(8):500-5. PubMed ID: 2300121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red-cell sodium-lithium countertransport and essential hypertension.
    Aronson PS
    N Engl J Med; 1982 Jul; 307(5):317. PubMed ID: 7088092
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetics of sodium-lithium countertransport in normotensive and hypertensive subjects.
    Siebers RW; Maling TJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S59-61. PubMed ID: 1708027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered membrane microviscosity in essential hypertension: relationship with family history of hypertension and sodium-lithium countertransport activity.
    Carr SJ; Sikand K; Moore D; Norman RI
    J Hypertens; 1995 Jan; 13(1):139-46. PubMed ID: 7759844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red-cell sodium-lithium countertransport and fractional excretion of lithium in normal and hypertensive humans.
    Weinberger MH; Smith JB; Fineberg NS; Luft FC
    Hypertension; 1989 Mar; 13(3):206-12. PubMed ID: 2493425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal sodium handling in ouabain-hypertensive rats].
    Ge H; Ren YP; Lui ZR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):461-5. PubMed ID: 16178440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte membrane cholesterol distribution in patients with untreated essential hypertension: correlation with sodium-lithium countertransport.
    Muriana FJ; Villar J; Ruíz-Gutiérrez V
    J Hypertens; 1996 Apr; 14(4):443-6. PubMed ID: 8761892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red cell lithium-sodium countertransport and sodium-potassium cotransport in patients with essential hypertension.
    Adragna NC; Canessa ML; Solomon H; Slater E; Tosteson DC
    Hypertension; 1982; 4(6):795-804. PubMed ID: 7141606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference between human red blood cell Na+-Li+ countertransport and renal Na+-H+ exchange.
    Kahn AM
    Hypertension; 1987 Jan; 9(1):7-12. PubMed ID: 2432011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in renal sodium transport during hypertension development in ouabain-hypertensive rats].
    Ge H; Lü ZR
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1404-7. PubMed ID: 17062336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-lithium countertransport in ambulatory hypertensive and normotensive patients.
    Turner ST; Boerwinkle E; Johnson M; Richelson E; Sing CF
    Hypertension; 1987 Jan; 9(1):24-34. PubMed ID: 2432010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte sodium/lithium countertransport and renal lithium clearance in a random sample of untreated middle-aged men.
    Strazzullo P; Cappuccio FP; Trevisan M; Iacoviello L; Iacone R; Jossa F; Giorgione N; Farinaro E; Mancini M
    Clin Sci (Lond); 1989 Sep; 77(3):337-42. PubMed ID: 2805596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased erythrocyte lithium--sodium countertransport in essential hypertension: its relationship to family history of hypertension.
    Canali M; Borghi L; Sani E; Curti A; Montanari A; Novarini A; Borghetti A
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():13s-15s. PubMed ID: 7318313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-lithium countertransport and cardiorenal abnormalities in essential hypertension.
    Nosadini R; Semplicini A; Fioretto P; Lusiani L; Trevisan R; Donadon V; Zanette G; Nicolosi GL; Dall'Aglio V; Zanuttini D
    Hypertension; 1991 Aug; 18(2):191-8. PubMed ID: 1885227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.